Articles
Drug rebates: a lethal spiral

Drug rebates: a lethal spiral

Offering rebates and price reductions gains market share in the short term, but in order to sustain the industry and in turn help patients, pharma needs to take a more collaborative approach an

Articles
Should pharma be envious of Apple?

Should pharma be envious of Apple?

Apple has just recorded the biggest profits in corporate history – how did it achieve this, and does pharma measure up in terms of innovation and marketing?

Articles
Healthcare meetings: focus on the patient

Healthcare meetings: focus on the patient

Healthcare meetings have long been important fixtures for pharma companies, healthcare professionals (HCPs) and medical societies to connect with each other in person and learn the latest devel

Sales & Marketing

Digital

Market Access

Newsletters and Deep Dive
digital magazine

Oncology

Oncology
Cancer cell

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

R&D